Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011:2011:481563.
doi: 10.4061/2011/481563. Epub 2011 Sep 4.

Prophylactic and Therapeutic Breast Conservation in BRCA1/2 Mutation Carriers

Randal L Croshaw  1 , Megan L Marshall, Tesha L Williams, Kathleen M Erb, Thomas B Julian
Affiliations

Prophylactic and Therapeutic Breast Conservation in BRCA1/2 Mutation Carriers

Randal L Croshaw et al. Int J Breast Cancer. 2011.

Abstract

Breast-conserving therapy (BCT) for sporadic breast cancer has been widely accepted by surgeons and patients alike. While BCT is associated with a higher risk of ipsilateral breast tumor recurrence (IBTR), it has not been shown to decrease overall survival (OS) in comparison with mastectomy. Many women with a BRCA1/2 mutation opt for mastectomy instead of breast-conserving measures at the time of a breast cancer diagnosis. In some cases, this is due to fear of aggressive disease, but to date, there have been no studies offering strong evidence that breast conservation should not be offered to these women. BRCA1/2-associated breast cancer has not been found to be more aggressive or resistant to treatment than comparable sporadic tumors, and no study has shown an actual survival advantage for mastectomy in appropriately treated affected mutation carriers. This paper reviews the available literature for breast conservation and surgical decision making in BRCA1/2 mutation carriers.

PubMed Disclaimer

References

    1. Hall JM, Lee MK, Newman B, et al. Linkage of early-onset familial breast cancer to chromosome 17q21. Science. 1990;250(4988):1684–1689. - PubMed
    1. Wooster R, Neuhausen SL, Mangion J, et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science. 1994;265(5181):2088–2090. - PubMed
    1. Kiebert GM, De Haes JC, Van de Velde CJ. The impact of breast-conserving treatment and mastectomy on the quality of life of early-stage breast cancer patients: a review. Journal of Clinical Oncology. 1991;9(6):1059–1070. - PubMed
    1. Schover LR. The impact of breast cancer on sexuality, body image, and intimate relationships. CA Cancer Journal for Clinicians. 1991;41(2):112–120. - PubMed
    1. Van Oostrom I, Meijers-Heijboer H, Lodder LN, et al. Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study. Journal of Clinical Oncology. 2003;21(20):3867–3874. - PubMed

LinkOut - more resources